SGLT2 inhibitors, GLP-1 RAs are effective, but costly in T2D | MDedge

Article Type

Changed

Tue, 05/03/2022 - 15:14

Author(s)

Publications

MDedge Internal Medicine

MDedge Family Medicine

Federal Practitioner

Type 2 Diabetes ICYMI

Topics

Sections

Author(s)

Author(s)

Publications

MDedge Internal Medicine

MDedge Family Medicine

Federal Practitioner

Type 2 Diabetes ICYMI

Publications

MDedge Internal Medicine

MDedge Family Medicine

Federal Practitioner

Type 2 Diabetes ICYMI

Topics

Article Type

Sections

Disallow All Ads

Content Gating

No Gating (article Unlocked/Free)

Alternative CME

Disqus Comments

Default

Gate On Date

Wed, 07/10/2019 - 08:30

Un-Gate On Date

Wed, 07/10/2019 - 08:30

Consolidated Pubs: Do Not Show Source Publication Logo

Use ProPublica

CFC Schedule Remove Status

Wed, 07/10/2019 - 08:30